{"name":"Center of Endourology \"Endocenter\"","slug":"center-of-endourology-endocenter","ticker":"","exchange":"","domain":"","description":"Center of Endourology 'Endocenter' is a specialized medical facility focused on endourological procedures and treatments, with a particular emphasis on the development and application of minimally invasive techniques. The center is involved in early-stage research, as evidenced by its single drug in Phase 1 trials, which is a micronized flavonoid fraction.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"micronized flavonoid fraction","genericName":"micronized flavonoid fraction","slug":"micronized-flavonoid-fraction","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"micronized flavonoid fraction","genericName":"micronized flavonoid fraction","slug":"micronized-flavonoid-fraction","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}